LIPE and cervical squamous cell carcinoma: Several recent studies have demonstrated that LIPE-AS1 is prominently expressed in BRCA and cervical squamous cell carcinoma and is associated with a higher survival rate (Xu et al., 2021; Wang et al., 2022).